Galunisertib enhances chimeric antigen receptor-modified T cell function

Chimeric antigen receptor (CAR) T cell therapy still faces the challenge of immunosuppression when treating solid tumors. TGF-β is one of the critical factors in the tumor microenvironment to help tumors escape surveillance by the immune system. Here we tried using the combination of a small molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhixiong, Liu, Qian, Risu, Na, Fu, Jiayu, Zou, Yan, Tang, Jiaxing, Li, Long, Liu, Hui, Zhou, Guomin, Zhu, Xuekai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388644/
https://www.ncbi.nlm.nih.gov/pubmed/32705856
http://dx.doi.org/10.4081/ejh.2020.3122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388644/
https://www.ncbi.nlm.nih.gov/pubmed/32705856
http://dx.doi.org/10.4081/ejh.2020.3122

Ejemplares similares